Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus

Avian Diseases

Volumn 52, Issue 1, 2008, Pages 111-117

  Sun, Hui Ling ^a,b,c   Wang, Yun Feng ^b   Tong, Guang Zhi ^a,b   Zhang, Pei Jun ^c   Miao, De Yuan ^c   Zhi, Hai Dong ^b   Wang, Ming ^a   Wang, Mei ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c INSTITUTE OF PLANT AND ENVIRONMENT PROTECTION   (China)

Author keywords

Infectious laryngotracheitis virus; Newcastle disease virus; Recombinant fowlpox virus

Indexed keywords

GB PROTEIN, INFECTIOUS LARYNGOTRACHEITIS VIRUS; HN PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BIRD DISEASE; BLOOD; CHICK EMBRYO; CHICKEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FOWLPOX VIRUS; GENETICS; HERPES VIRUS INFECTION; ILTOVIRUS; IMMUNOLOGY; METABOLISM; RANDOMIZATION;

ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOWLPOX VIRUS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; HN PROTEIN; NEWCASTLE DISEASE; RANDOM ALLOCATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

AVES; FOWLPOX VIRUS; GALLID HERPESVIRUS 1; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 41849098864     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/7998-041807-Reg     Document Type: Article

References (42)

1. Adair, B. M., D. Todd, E. R. Mckillop, and K. Burns. Comparison of serological tests for detection of antibodies to infectious laryngotracheitis virus. Avian Pathol. 14:461-469. 1985.
2. Alexander, D. J. Newcastle disease: methods of spread. In: Newcastle disease, D. J. Alexander, ed. Kluwer Academic Publishers, Boston, MA. pp. 256-272. 1988.
3. Bagust, T. Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathol. 15:581-595. 1986.
4. Bagust, T., and J. S. Guy. Laryngotracheitis. In: Diseases of poultry, 10th ed. B. W. Calnek, ed. Iowa State University Press, Ames, IA. pp. 527-539. 1997.
5. Beard, C. W., W. M. Schnitzlein, and D. N. Tripathy. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 35:356-359. 1991.
6. Bolte, A. L., J. Meurer, and E. F. Kaleta. Avian host spectrum of avipoxviruses. Avian Pathol. 28:415-432. 1999.
7. Boursnell, M. E., P. F. Green, J. I. Campbell, A. Deuter, R. W. Peters, F. M. Tomley, A. C. Samson, P. T. Emmerson, and M. M. Binns. A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus. Vet. Microbiol. 23:305-316. 1990a.
8. Boursnell, M. E., P. F. Green, A. C. Samson, J. I. Campbell, A. Deuter, R. W. Peters, N. S. Millar, P. T. Emmerson, and M. M. Binns. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178:297-300. 1990b.
9. Chambers, T. M., Y. Kawaoka, and R. G. Webster. Protection of chickens from lethal influenza infection by vaccinia-expressed haemagglutinin. Virology 167:414-421. 1988.
10. Clarke, J. K., G. M. Robertson, and D. A. Purcell. Spray vaccination of chickens using infectious laryngotracheitis virus. J. Aust. Vet. 56:424-428. 1980.
11. Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH and gl): comparative protection against lethal challenge in mice. J. Virol. 68:2118-2126. 1994.
12. Gough, R. E., and D. J. Alexander. The speed of resistance to challenge induced in chickens vaccinated by different routes with a B1 strain of live NDV. Vet. Rec. 92:563-564. 1973.
13. Hanson, L. L. I. H. M., H. J. Barnes, B. W. Calnek, W. M. Reid, and H. W. Yoder, Jr., eds. Diseases of poultry, 8th ed. Iowa State University Press, Ames, IA. pp. 444-451. 1984.
14. Harley, V. R., P. J. Hudson, B. E. Coupar, P. W. Selleck, H. Westbury, and D. B. Boyle. Vaccinia virus expression and sequence of an influenza Nucleoprotein gene: potential use in diagnosis. Arch. Virol. 113(1-2):133-141. 1990.
15. Karaca, K., J. M. Sharma, B. J. Winslow, D. E. Junker, S. Reddy, M. Cochran, and J. McMillen. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16:1496-1503. 1998.
16. King, D. J. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge. Avian Dis. 43:745-755. 1999.
17. Leong, K. H., A. J. Ramsay, D. B. Boyle, and I. A. Ramshaw. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 68:8125-8130. 1994.
18. Letellier, C., A. Burny, and G. Meulemans. Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch. Virol. 118:43-56. 1991.
19. Meulemans, G., M. Gonze, M. C. Carlier, P. Petit, A. Burny, and L. Long. Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease. Avian Pathol. 15:761-768. 1986.
20. Meulemans, G., C. Letellier, M. Gonze, M. C. Carlier, and A. Burny. Newcastle disease virus F glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live virus challenge. Avian Pathol. 17:821-827. 1988.
21. Nagai, Y., H.-D. Klenk, and R. Rott. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72:494-508. 1976.
22. Nagai, Y., K. Shimokata, T. Yoshida, M. Hamaguchi, M. Innuma, K. Maeno, T. Hashimoto, H.-D. Klenk, and R. Rott. Newcastle disease virus in chick embryo as depending on the protease sensitivity of the virus glycoproteins. J. Virol. 45:263-272. 1979.
23. Nazerian, K., and N. Yanagida. A recombinant fowlpox virus expressing the envelope antigen of subgroup A avian leukosis/sarcoma virus. Avian Dis. 39:514-520. 1995.
24. Nazerian, K., R. L. Witter, L. F. Lee, and N. Yanagida. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:368-376. 1996.
25. Nishikawa, K., S. Isomura, S. Suzuki, E. Watanabe, M. Hamaguchi, T. Yoshida, and Y. Nagai. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318-330. 1983.
26. Nishino, Y., M. Niikura, T. Suwa, M. Onuma, B. Gotoh, Y. Nagai, and T. Mikami. Analysis of the protective effect of the haemagglutininneuraminidase protein in Newcastle disease virus infection. J. Gen. Virol. 72(Pt5):1187-1190. 1991.
27. Qiao, C. L., K. Z. Yu, Y. P. Jiang, Y. Q. Jia, G. B. Tian, M. Liu, G. H. Deng, X. R. Wang, Q. W. Meng, and X. Y. Tang. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32:25-31. 2003.
28. Rautenschlein, S., J. M. Sharma, B. J. Winslow, J. McMillen, D. Junker, and M. Cochran. Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants. Vaccine 18:426-433. 1999.
29. Roth, J., D. Dittmer, D. Rea, J. Tartaglia, E. Paoletti, and A. J. Levine. p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge. Proc. Natl. Acad. Sci. USA 93:4781-4786. 1996.
30. Schlom, J., and D. Panicali. Recombinant poxvirus vaccines. In: Principles and practice of the biologic therapy of cancer, 3rd ed. S. A. Rosenberg, ed. J. B. Lippincott Co., Philadelphia, PA. pp. 686-694. 2000.
31. Sun, H. L., Y. F. Wang, D. Y. Miao, P. J. Zhang, H. D. Zhi, L. L. Xu, M. Wang, G. Z. Tong, and M. Wang. Construction and characterization of a recombinant fowlpox virus co-expressing F, HN genes of Newcastle disease virus and gB gene of infectious larygnotracheitis virus. Chin. J. Biotechnol. 22:931-939. 2006.
32. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095. 2000.
33. Taylor, J., and E. Paoletti. Fowlpox virus as a vector in non-avian species. Vaccine 6:466-468. 1988.
34. Taylor, J., L. Christensen, R. Gettig, J. Goebel, J. F. Bouquet, T. R. Mickle, and E. Paoletti. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge. Avian Dis. 40:173-180. 1996.
35. Taylor, J., C. Edbauer, A. Rey-Senelonge, J. F. Bouquet, E. Norton, S. Goebel, P. Desmettre, and E. Paoletti. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64:1441-1450. 1990.
36. Taylor, J., R. Weinberg, B. Languet, P. Desmettre, and E. Paoletti. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6:497-503. 1988b.
37. Tong, G. Z., S. J. Zhang, S. S. Meng, L. Wang, H. J. Qiu, Y. F. Wang, L. Yu, and M. Wang. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol. 30:143-148. 2001.
38. Ulmer, J. B., R. R. Deck, C. M. Dewitt, T. M. Fu, J. J. Donnelly, M. J. Caulfield, and M. A. Liu. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine 15(8):839-841. 1997.
39. Umino, Y., T. Kohama, M. Kohase, A. Sugiura, H. D. Klenk, and R. Rott. Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus. Arch. Virol. 94:97-107. 1987.
40. Umino, Y., T. Kohama, T. A. Sato, and A. Sugiura. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization. J. Gen. Virol. 71(Pt5):1199-1203. 1990.
41. Wang, M., V. Bronte, P. W. Chen, L. Gritz, D. Panicali, S. A. Rosenberg, and N. P. Restifo. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:4685-4692. 1995.
42. Wang, X. K., X. Y. Tang, G. X. Xin, and Q. X. Liu. Development of neutralization test for avian infectious laryngotracheitis. Chin. J. Anim. Infect. Dis. 4:13-17. 1982.